Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLP-J Inhibitors

PLP-J inhibitors are a class of chemical compounds designed to target pyridoxal phosphate-dependent enzyme J (PLP-J), part of the broad family of enzymes that rely on pyridoxal 5'-phosphate (PLP) as a cofactor. PLP-J, like other PLP-dependent enzymes, plays a crucial role in catalyzing reactions central to amino acid metabolism, including transamination, decarboxylation, and racemization. These reactions are fundamental for the synthesis and conversion of amino acids, which serve as building blocks for proteins and are involved in numerous metabolic processes. By regulating these reactions, PLP-J ensures the proper functioning of metabolic pathways that control protein biosynthesis, nitrogen metabolism, and cellular energy production. Inhibiting PLP-J disrupts these processes, affecting amino acid availability and metabolism.

The mechanism of PLP-J inhibitors involves binding to the enzyme's active site or interacting with its PLP-binding domain, preventing PLP-J from facilitating its normal catalytic activities. This inhibition alters the flow of amino acid-related metabolic pathways, potentially leading to changes in how cells synthesize proteins, process nutrients, and manage metabolic waste. Researchers use PLP-J inhibitors as tools to explore the role of this enzyme in maintaining amino acid homeostasis and to understand its broader impact on cellular metabolism. By blocking PLP-J activity, scientists can investigate the enzyme's contribution to critical biochemical processes and gain insights into how disruptions in PLP-dependent enzymatic activity affect cellular functions such as growth, energy metabolism, and signaling. These inhibitors offer valuable opportunities to study the regulatory mechanisms that govern amino acid metabolism and their role in supporting overall cellular and metabolic health.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bromocriptine

25614-03-3sc-337602A
sc-337602B
sc-337602
10 mg
100 mg
1 g
$57.00
$265.00
$567.00
4
(1)

A dopamine D2 receptor agonist that inhibits prolactin secretion, potentially affecting related prolactin family proteins indirectly.

Cabergoline

81409-90-7sc-203864
sc-203864A
10 mg
50 mg
$300.00
$1055.00
(0)

Another dopamine agonist with a longer half-life than Bromocriptine, reducing prolactin levels and potentially influencing prolactin-related protein activity.

Mifepristone

84371-65-3sc-203134
100 mg
$61.00
17
(1)

A glucocorticoid and progesterone receptor antagonist that may indirectly affect prolactin family protein expression through hormonal regulation pathways.

Trilostane

13647-35-3sc-208469
sc-208469A
10 mg
100 mg
$228.00
$1217.00
2
(1)

An inhibitor of 3β-hydroxysteroid dehydrogenase, which can alter steroid biosynthesis and potentially impact prolactin-related protein functions.